Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXNX
3126
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.43M | ﹤0.01% |
128,754
+70,540
| +121% | +$3.31M |
|
|
CRON
3127
PUT
Cronos Group
CRON
$1.16B
| $6.42M | ﹤0.01% |
925,800
-274,400
| -23% | -$1.89M |
|
3128
Jefferies Financial Group
JEF
$12.7B
| $6.42M | ﹤0.01% |
272,951
-597,161
| -69% | -$12.5M |
|
3129
PUT
Carrier Global
CARR
$51.8B
| $6.42M | ﹤0.01% |
170,109
+102,609
| +152% | +$3.71M |
|
3130
Encore Capital Group
ECPG
$2.2B
| $6.41M | ﹤0.01% |
164,680
+117,445
| +249% | +$4.27M |
|
|
VVNT
3131
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $6.41M | ﹤0.01% |
309,089
+100,785
| +48% | +$2M |
|
3132
CALL
InMode
INMD
$872M
| $6.41M | ﹤0.01% |
270,000
+118,200
| +78% | +$2.5M |
|
3133
iShares MSCI USA Size Factor ETF
SIZE
$447M
| $6.41M | ﹤0.01% |
57,646
+27,034
| +88% | +$2.8M |
|
3134
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$329M
| $6.41M | ﹤0.01% |
16,381
+8,890
| +119% | +$4.23M |
|
3135
ARS Pharmaceuticals
SPRY
$562M
| $6.4M | ﹤0.01% |
+138,138
| New | +$4.61M |
|
3136
CryoPort
CYRX
$772M
| $6.4M | ﹤0.01% |
145,756
-102,839
| -41% | -$4.9M |
|
3137
PUT
Regions Financial
RF
$27.2B
| $6.39M | ﹤0.01% |
396,700
-92,500
| -19% | -$1.34M |
|
3138
CALL
CEL-SCI Corp
CVM
$26.9M
| $6.39M | ﹤0.01% |
18,263
-1,704
| -9% | -$672K |
|
3139
PUT
Park Hotels & Resorts
PK
$3.05B
| $6.39M | ﹤0.01% |
372,500
+224,800
| +152% | +$3.12M |
|
|
USCR
3140
CALL
DELISTED
U S Concrete, Inc.
USCR
| $6.39M | ﹤0.01% |
159,800
-17,500
| -10% | -$622K |
|
3141
CALL
NeoGenomics
NEO
$2.05B
| $6.38M | ﹤0.01% |
118,600
+68,000
| +134% | +$3.07M |
|
|
SKX
3142
CALL
DELISTED
Skechers
SKX
| $6.38M | ﹤0.01% |
177,500
-66,400
| -27% | -$2.26M |
|
3143
PUT
Zions Bancorporation
ZION
$10.5B
| $6.38M | ﹤0.01% |
146,800
+20,500
| +16% | +$758K |
|
3144
RBC Bearings
RBC
$17.7B
| $6.38M | ﹤0.01% |
35,609
-15,957
| -31% | -$2.44M |
|
3145
CALL
Under Armour Class C
UA
$2.26B
| $6.37M | ﹤0.01% |
427,900
+9,500
| +2% | +$127K |
|
3146
PUT
Protolabs
PRLB
$2.2B
| $6.37M | ﹤0.01% |
41,500
+11,700
| +39% | +$1.65M |
|
|
ZUO
3147
CALL
DELISTED
Zuora, Inc.
ZUO
| $6.36M | ﹤0.01% |
456,700
+218,800
| +92% | +$2.49M |
|
|
ANSS
3148
DELISTED
Ansys
ANSS
| $6.36M | ﹤0.01% |
17,471
+15,051
| +622% | +$5.04M |
|
|
PPL
3149
PUT
PPL Corp
PPL
$27.1B
| $6.34M | ﹤0.01% |
225,000
+80,700
| +56% | +$2.29M |
|
|
AYX
3150
DELISTED
Alteryx Inc
AYX
| $6.34M | ﹤0.01% |
52,034
+25,063
| +93% | +$3.16M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.